Latest Articles

Publication Date
Unraveling the VEGF-ETS1 axis: a transcriptomic and single-cell analysis of angiogenesis in endometriosis.

Endometriosis (EM) is a chronic inflammatory gynecological disorder characterized by ectopic endometrial-like lesions, where aberrant angiogenesis is a hallmark driving lesion establishment and progression. However, the transcriptional mechanisms underlying pathological …

Published: Jan. 16, 2026, midnight
Endometriosis as a Systemic and Complex Disease: Toward Phenotype-Based Classification and Personalized Therapy.

Endometriosis is traditionally conceptualized as a pelvic lesion-centered disease; however, mounting evidence indicates it is a chronic, systemic, and multifactorial inflammatory disorder. This review examines the molecular dialog between ectopic …

Published: Jan. 16, 2026, midnight
Collision tumor of endometrial hepatoid adenocarcinoma and endometrial stromal sarcoma: a rare case and literature review.

Endometrial hepatoid adenocarcinoma (HAC) is an exceedingly rare tumor. Histologically, the tumor is predominantly characterized by HAC with additional components, as documented in previous reports. The coexistence of endometrial HAC …

Published: Jan. 16, 2026, midnight
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer - Cancer Health

Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer Cancer Health

Published: Jan. 15, 2026, 1:34 p.m.
Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers - koreabiomed.com

Ulsan team reports single-port robotic surgery removing colorectal and endometrial cancers koreabiomed.com

Published: Jan. 15, 2026, 6:21 a.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News

Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News

Published: Jan. 14, 2026, 7:32 p.m.
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity TipRanks

Published: Jan. 14, 2026, 4:33 p.m.
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com

Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com

Published: Jan. 14, 2026, 6:02 a.m.
Investigation of endothelin-1 receptor antagonist bosentan in a rat endometriosis model.

The study aimed to investigate the roles of endothelin-1 and endothelin receptors in a rat endometriosis model and to demonstrate how bosentan (BOS), an endothelin receptor blocker, could potentially serve …

Published: Jan. 14, 2026, midnight
Focal Atypical Endometrial Hyperplasia Arising Within a Deeply Infiltrating Bladder Endometriotic Nodule.

This report presents a patient with deeply infiltrating bladder endometriosis who underwent laparoscopic excision with partial cystectomy, revealing focal atypical endometrial hyperplasia within the bladder nodule on histopathology. The case …

Published: Jan. 14, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!